Trial Profile
Rosuvastatin Effect on Atherosclerotic Plaque Metabolism - a Subclinical Atherosclerosis Imaging Study With 18F-NaF PET-CT
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2022
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- Acronyms ROPPET-NAF
- 27 Oct 2022 Status changed from recruiting to completed.
- 22 May 2022 Planned End Date changed from 1 Oct 2021 to 1 Oct 2022.
- 22 May 2022 Planned primary completion date changed from 1 Jul 2021 to 20 Jun 2022.